| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 665401 | 72298 | PANTOPRAZOL TEVA-RATIO 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TEVA-RATIO 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (FRASCO) | 40 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72298/72298_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72298/72298_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2010-05-26 | 1 | 1 | 1 | 2010-05-26 | 2010-05-26 | 1 | 2016-09-12 | View Edit Delete | ||||||||||||
| 664955 | 71988 | ECHINAMED COMPRIMIDOS | ECHINAMED COMPRIMIDOS, 30 comprimidos | 1.140 mg/60 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71988/71988_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71988/71988_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21241 | BIOFORCE ESPANA A VOGEL S.A. | 2010-03-18 | 1 | 1 | 1 | 2010-03-18 | 2010-03-18 | 1 | 2011-10-10 | View Edit Delete | ||||||||||||
| 663871 | 00146031 | KEPPRA 100 mg/ml SOLUCION ORAL | KEPPRA 100 mg/ml SOLUCION ORAL, 1 frasco de 150 ml con jeringa oral de 5 ml | 100 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml con jeringa oral de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/00146031/00146031_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/00146031/00146031_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8910 | UCB PHARMA S.A. | 2009-12-02 | 1 | 1 | 1 | 2009-12-02 | 2009-12-02 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 663873 | 00146032 | KEPPRA 100 mg/ml SOLUCION ORAL | KEPPRA 100 mg/ml SOLUCION ORAL, 1 frasco de 150 ml con jeringa oral de 1 ml | 100 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml con jeringa oral de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/00146032/00146032_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/00146032/00146032_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8910 | UCB PHARMA S.A. | 2009-12-02 | 1 | 1 | 1 | 2009-12-02 | 2009-12-02 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 664565 | 61848 | ATROVENT NASAL 0,30 mg/ml SOLUCION PARA PULVERIZACION NASAL | ATROVENT NASAL 0,30 mg/ml SOLUCION PARA PULVERIZACION NASAL, 1 envase pulverizador de 15 ml | 0,3 mg/ml | 6 | 15 | 26 | 1 envase pulverizador de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61848/61848_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61848/61848_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 1998-05-01 | 1 | 1 | 1 | 1998-05-01 | 1998-05-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 664795 | 71103 | LATANOPROST STADA 50 microgramos/ml COLIRIO EN SOLUCION | LATANOPROST STADA 50 microgramos/ml COLIRIO EN SOLUCION , 1 frasco de 2,5 ml | 50 microgramos/ml | 6 | 2,5 | 26 | 1 frasco de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71103/71103_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71103/71103_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2010-02-16 | 1 | 1 | 1 | 2010-02-16 | 2010-02-16 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 664868 | 71913 | RIVASTIGMINA NORMON 2 mg/ml SOLUCION ORAL EFG | RIVASTIGMINA NORMON 2 mg/ml SOLUCION ORAL EFG, 1 frasco de 120 ml | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71913/71913_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71913/71913_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-02-24 | 1 | 1 | 1 | 2010-02-24 | 2010-02-24 | 1 | 2012-08-01 | View Edit Delete | ||||||||||||
| 663771 | 09533002 | VEDROP 50 MG/ML EN SOLUCION ORAL | VEDROP 50 MG/ML EN SOLUCION ORAL, 1 frasco de 20 ml | 50 mg/ml | 6 | 20 | 26 | 1 frasco de 20 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/09533002/09533002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09533002/09533002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2009-12-02 | 1 | 1 | 1 | 2009-12-02 | 2009-12-02 | 1 | 2011-05-10 | View Edit Delete | ||||||||||||
| 663772 | 09533003 | VEDROP 50 MG/ML EN SOLUCION ORAL | VEDROP 50 MG/ML EN SOLUCION ORAL, 1 frasco de 60 ml | 50 mg/ml | 6 | 60 | 26 | 1 frasco de 60 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/09533003/09533003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09533003/09533003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2009-12-02 | 1 | 1 | 1 | 2009-12-02 | 2009-12-02 | 1 | 2011-11-18 | View Edit Delete | ||||||||||||
| 663822 | 71356 | CUVENAX 35 microgramos/PULSACION SOLUCION PARA PULVERIZACION NASAL | CUVENAX 35 microgramos/PULSACION SOLUCION PARA PULVERIZACION NASAL, 1 frasco de 15 ml | 0,5 mg/ml | 6 | 15 | 26 | 1 frasco de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71356/71356_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71356/71356_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23862 | PHARMEX ADVANCED LABORATORIES S.L. | 2009-08-31 | 1 | 1 | 1 | 2018-07-19 | 2018-07-19 | 1 | 2018-10-18 | View Edit Delete | ||||||||||||
| 664929 | 72005 | SEHCAT 370 KBQ CAPSULAS | SEHCAT 370 KBQ CAPSULAS, 1 cápsula | 370 kBq | 6 | 1 | 43 | 1 cápsula | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72005/72005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72005/72005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 10603 | GE HEALTHCARE BIO-SCIENCES, S.A.U. | 2010-03-24 | 1 | 1 | 1 | 2010-03-24 | 2010-03-24 | 1 | 2011-10-10 | View Edit Delete | ||||||||||||
| 664463 | 71778 | RIVASTIGMINA KERN PHARMA 2 mg/ml SOLUCION ORAL EFG | RIVASTIGMINA KERN PHARMA 2 mg/ml SOLUCION ORAL EFG , 1 frasco de 120 ml con jeringa dosificadora | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml con jeringa dosificdora | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71778/71778_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71778/71778_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2009-12-16 | 1 | 1 | 1 | 2009-12-16 | 2009-12-16 | 1 | 2012-09-19 | View Edit Delete | ||||||||||||
| 664443 | 71776 | PASIFLORA ARKOPHARMA cápsulas duras | PASIFLORA ARKOPHARMA cápsulas duras, 45 cápsulas | 300 mg | 6 | 45 | 43 | 45 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71776/71776_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71776/71776_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 23799 | ARKOPHARMA LABORATORIOS S.A.U. | 2009-12-16 | 1 | 1 | 1 | 2009-12-16 | 2009-12-16 | 0 | 2011-04-25 | View Edit Delete | ||||||||||||
| 664444 | 71776 | PASIFLORA ARKOPHARMA cápsulas duras | PASIFLORA ARKOPHARMA cápsulas duras , 84 cápsulas | 300 mg | 6 | 84 | 43 | 84 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71776/71776_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71776/71776_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 23799 | ARKOPHARMA LABORATORIOS S.A.U. | 2009-12-16 | 1 | 1 | 1 | 2009-12-16 | 2011-05-04 | 0 | 2011-10-26 | View Edit Delete | ||||||||||||
| 664951 | 71989 | COLA DE CABALLO ARKOPHARMA cápsulas duras | COLA DE CABALLO ARKOPHARMA cápsulas duras , 50 cápsulas | 190 mg | 6 | 50 | 43 | 50 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71989/71989_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71989/71989_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 23799 | ARKOPHARMA LABORATORIOS S.A.U. | 2010-03-24 | 1 | 1 | 1 | 2010-03-24 | 2010-03-24 | 0 | 2011-04-25 | View Edit Delete | ||||||||||||
| 664952 | 71989 | COLA DE CABALLO ARKOPHARMA cápsulas duras | COLA DE CABALLO ARKOPHARMA cápsulas duras , 100 cápsulas | 190 mg | 6 | 100 | 43 | 100 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71989/71989_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71989/71989_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 23799 | ARKOPHARMA LABORATORIOS S.A.U. | 2010-03-24 | 1 | 1 | 1 | 2010-03-24 | 2010-03-24 | 0 | 2011-04-25 | View Edit Delete | ||||||||||||
| 665438 | 72461 | VALERIANA ARKOPHARMA cápsulas duras | VALERIANA ARKOPHARMA cápsulas duras , 84 cápsulas | 350 mg | 6 | 84 | 43 | 84 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72461/72461_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72461/72461_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 23799 | ARKOPHARMA LABORATORIOS S.A.U. | 2010-06-28 | 1 | 1 | 1 | 2010-06-28 | 2011-05-04 | 0 | 2011-10-26 | View Edit Delete | ||||||||||||
| 664782 | 71692 | ALBUREX 50 g/L SOLUCION PARA PERFUSION | ALBUREX 50 g/L SOLUCION PARA PERFUSION, 1 frasco de 250 ml | 50 g/L inyectable perufisón 250 ml | 6 | 1 | 48 | 1 frasco de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71692/71692_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71692/71692_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | CSL BEHRING S.A. | 2010-02-09 | 1 | 1 | 1 | 2010-02-09 | 2010-02-09 | 1 | 2012-10-22 | View Edit Delete | ||||||||||||
| 664783 | 71692 | ALBUREX 50 g/L SOLUCION PARA PERFUSION | ALBUREX 50 g/L SOLUCION PARA PERFUSION, 1 frasco de 500 ml | 50 g/L inyectable perufisón 500 ml | 6 | 1 | 48 | 1 frasco de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71692/71692_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71692/71692_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | CSL BEHRING S.A. | 2010-02-09 | 1 | 1 | 1 | 2010-02-09 | 2010-02-09 | 1 | 2013-12-13 | View Edit Delete | ||||||||||||
| 664785 | 71694 | ALBUREX 200 g/L SOLUCION PARA PERFUSION | ALBUREX 200 g/L SOLUCION PARA PERFUSION, 1 frasco de 50 ml | 200 g/L inyectable perfusión 50 ml | 6 | 1 | 48 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71694/71694_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71694/71694_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | CSL BEHRING S.A. | 2010-02-09 | 1 | 1 | 1 | 2010-02-09 | 2010-02-09 | 1 | 2012-10-22 | View Edit Delete |
Page 218 of 1035, showing 20 records out of 20689 total, starting on record 4341, ending on 4360